FDA Clearance Tracker · K230112
CAC Software
Last checked: Nov 19, 2026Latest source record: Jun 13, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Jun 13, 2023
Substantially Equivalent
Time to decision
147 days
Received Jan 17, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K230112
- Device name
- CAC Software
- Applicant
- Imbio, Inc.
- Applicant location
- Minneapolis, MN
- Received
- Jan 17, 2023
- Decided
- Jun 13, 2023
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- System, X-Ray, Tomography, Computed (JAK)
- Device class
- Class II
- Regulation
- 21 CFR 892.1750
- Specialty
- Radiology & Imaging
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code JAK. The earliest in FDA's data is K760688, decided Oct 5, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K230112
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Imbio, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- IQ-UIPBreakthrough510(k)
K242467 · Decided Dec 19, 2024 · 121 days after receipt
Device type: Radiology Software For Referral Of Findings Related To Fibrotic Lung Disease. (QWO) · Radiology & Imaging
- Imbio PHA (4.0.0)510(k)
K241847 · Decided Aug 30, 2024 · 65 days after receipt
Device type: Automated Radiological Image Processing Software (QIH) · Radiology & Imaging
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.